Demethylating agent 5-aza-2′-deoxycytidine activates HLA-G expression in human leukemia cell lines

被引：25

作者：

Polakova, K. ^{[2
]}

Bandzuchova, E. ^{[3
]}

Kuba, D. ^{[3
]}

Russ, G. ^{[1
]}

机构：

[1] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia

[2] Slovak Acad Sci, Canc Res Inst, Bratislava 84505, Slovakia

[3] Slovak Med Univ, Bratislava, Slovakia

来源：

LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期

关键词：

HLA-G; Leukemia cells; Demethylation; 5-Aza-2 '-deoxycytidine; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-CELLS; G GENE; PROMOTER REGION; CANCER; DNA; DECITABINE; INHIBITORS; PROTEINS;

D O I：

10.1016/j.leukres.2008.08.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

HLA-G is a non-classical HLA class I antigen primarily expressed in the extravillous cytotrophoblast. HLA-G can also be expressed at some pathological circumstances and may thus contribute to inhibition of efficient immune responses. Complex regulation of HLA-G expression also involves epigenetic mechanisms as DNA methylation. Here we demonstrate that treatment with demethylating agent 5-aza-2'-deoxycytidine (AdC) resulted in HLA-G transcription in 18 out of 20 examined leukemia cell lines. FILA-G protein synthesis was detected in 10 cell lines expressing significant level of HLA-G transcripts following AdC treatment. (C) 2008 Elsevier Ltd. All rights reserved

引用

页码：518 / 524

页数：7

共 50 条

[1] Activation of HLA-G expression by 5-aza-2′ - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients
Polakova, K.
Bandzuchova, E.
Sabty, F. A.
Mistrik, M.
Demitrovicova, L.
Russ, G.
NEOPLASMA, 2009, 56 (06) : 514 - 520
[2] Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine
Chien Chung CHANG
Soldano FERRONE
Cell Research, 2005, (07) : 523 - 531
[3] Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2′-deoxycytidine
Wei Hua YAN
Ai Fen LIN
Chien Chung CHANG
Soldano FERRONE
Cell Research, 2005, 15 : 523 - 531
[4] Delineating the effect of demethylating agent 5-aza-2′deoxycytidine on human Caco-2 colonic carcinoma cells
Li, Xiumei
Qin, Bingzhao
Liu, Bo
ONCOLOGY LETTERS, 2016, 12 (01) : 139 - 143
[5] Treatment with demethylating agent, 5-aza-2′-deoxycytidine enhances therapeutic HPV DNA vaccine potency
Lu, Dan
Hoory, Talia
Monie, Archana
Wu, Annie
Wang, Mei-Cheng
Hung, Chien-Fu
VACCINE, 2009, 27 (32) : 4363 - 4369
[6] RETRACTED: Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2′-deoxycytidine (Retracted Article)
Yan, WH
Lin, AF
Chang, CC
Ferrone, S
CELL RESEARCH, 2005, 15 (07) : 523 - 531
[7] Demethylating agent 5-aza-2′-deoxycytidine enhances expression of TNFRI and promotes TNF-mediated apoptosis in vitro and in vivo
Kaminski, R
Kozar, K
Niderla, J
Grzela, T
Wilczynski, G
Skierski, JS
Koronkiewicz, M
Jakobisiak, M
Golab, J
ONCOLOGY REPORTS, 2004, 12 (03) : 509 - 516
[8] MAGED4 Expression in Glioma and Upregulation in Glioma Cell Lines with 5-Aza-2'-Deoxycytidine Treatment
Zhang, Qing-Mei
Shen, Ning
Xie, Sha
Bi, Shui-Qing
Luo, Bin
Lin, Yong-Da
Fu, Jun
Zhou, Su-Fang
Luo, Guo-Rong
Xie, Xiao-Xun
Xiao, Shao-Wen
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (08) : 3495 - 3501
[9] An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients
P. W. Wijermans
M. Lübbert
G. Verhoef
V. Klimek
A. Bosly
Annals of Hematology, 2005, 84 : 9 - 17
[10] An epigenetic approach to the treatment of advanced MDS;: the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients
Wijermans, PW
Lübbert, M
Verhoef, G
Klimek, V
Bosly, A
ANNALS OF HEMATOLOGY, 2005, 84 (Suppl 1) : 9 - 17

← 1 2 3 4 5 →